01
ABOUT THE EVENT
Global Virtual Conference on Streptococcus
Research Symposium
STREPTOCOCCI 2026
April 27–28, 2026
Format: Virtual (EDT)
Organized by: Impact Research Communications
The 2026 Global Virtual Streptococcus Research Symposium
brought together leading microbiologists, immunologists,
and clinicians to advance understanding of
Streptococcus pathogenesis, immunity, and clinical
outcomes. Over two days, the symposium highlighted
breakthroughs in host-pathogen crosstalk, immune evasion,
biofilm biology, and antimicrobial resistance—underscoring
the urgent need for innovation in tackling streptococcal
diseases worldwide.
03
DAY 2
Day 2: Relapse, Biofilms & Antimicrobial Resistance
Session IV: Relapse & Colonization Dynamics
-
Dr. Timothy Barnett (Australia)
provided insights into relapse infections in
Group A Streptococcus.
-
Dr. Justin Zik (Singapore)
applied dual transposon sequencing to map
bacterial genetic interactions.
-
Dr. Sven Hammerschmidt (Germany)
examined pneumococcal cross-talk at colonization
and invasive disease boundaries.
-
Dr. Shaynor Dramsi (France)
studied S. gallolyticus interactions
with human colonic mucus.
Session V: Biofilms & Genetic Susceptibility
-
Dr. Marcus Fulde (Germany)
discussed host-pathogen dynamics in
Streptococcus canis.
-
Ms. Diana Pohlman (USA)
presented efforts to build a genetic susceptibility
repository for PANDAS and Sydenham chorea.
-
Dr. Pratyush Madapuji Ravi (USA)
highlighted high-throughput imaging assays
for S. pneumoniae biofilm lifecycle genes.
Session VI: Vaccines, Resistance & Clinical Perspectives
-
Dr. Eileen M. Dunne (USA)
reported on pneumococcal conjugate vaccine
effectiveness.
-
Dr. Andrew Fenton (UK)
addressed strategies to overcome penicillin
resistance in S. pneumoniae.
-
Dr. Laia Pasquina Lemonche (UK)
used AFM imaging to reveal antibiotic-induced
cell wall damage.
-
Dr. Slawomir Lukomski (USA)
discussed invasive emm92-type GAS infections
and MLSB resistance.
-
Dr. Saugata Majumder (USA)
demonstrated enhanced lung-resident immunity
via intranasal PSpA boosting.
-
Dr. Stephanie S. Momeni (USA)
advanced perspectives on S. mutans
in early childhood dental caries.
The symposium closed with remarks highlighting the
convergence of immunology, genomics, and clinical research
in advancing streptococcal disease management.
04
INTERNATIONAL COLLABORATION
Global Participation
Countries represented included:
USA, UK, Germany, Italy, France, Australia, Singapore
,
and others—reflecting the international scope of
streptococcal research and clinical collaboration.